Pertussis Toxin (islet-activating protein)
A toxin used in GPCR and EAE research
CAS No. 70323-44-3
Item No. 19546
Formulation: Each vial, when reconstituted to 500 μl with water, contains 50 μg of pertussis toxin in in 0.01 M sodium phosphate, 0.05 M sodium chloride, pH 7.0
Purity: ≥95% estimated by SDS-PAGE
Pertussis Toxin from Bordetella pertussis (lyophilized, salt free)
A toxin used in GPCR and EAE research
Item No. 23221
Formulation: 50 µg of lyophilized pertussis toxin
Purity: ≥95% (estimated by SDS-PAGE)
Formulation: A crystalline solid
Purity: ≥98%
- NSC 55929
Pertussis Toxin from Bordetella pertussis (in glycerol)
A toxin used in GPCR and EAE research
Item No. 23220
Formulation: 50 μg of pertussis toxin in 50% glycerol, 0.05 M Tris, 0.01 M glycine, 0.5 M sodium chloride, pH 7.5, at a concentration of 0.15 mg/ml
Purity: ≥95% (estimated by SDS-PAGE)
Erythromycin-13C-d3
An internal standard for the quantification of erythromycin
CAS No. 2378755-50-9
Item No. 25310
Formulation: A solid
Purity: ≥99% deuterated forms (d1-d3)
Pseudoerythro
A degradation product of erythromycin
CAS No. 105882-69-7
Item No. 15508
Formulation: A solid
Purity: ≥98%
- LY267108
Adenylate Cyclase Toxin from Bordetella pertussis (recombinant, frozen liquid)
A virulence factor in B. pertussis
Item No. 28211
Formulation: Each vial contains 50 µg of recombinant adenylate cyclase toxin in 39 µl of 0.05 M Tris-HCl, 8 M urea, pH 8.0
Purity: ≥90% (estimated by SDS-PAGE)
- Adenylyl Cyclase Toxin
Formulation: A solid
Purity: ≥95%
Formulation: A crystalline solid
Purity: ≥95%
- Antibiotic AS-E 136
- LY237216
Immunogen: Recombinant mouse C-terminal His-tagged CD64 extracellular domain
Host: Rabbit
Isotype: IgG
Applications: FC, ICC, IF
2',3'-O-(Bis-[5-bromoanthraniloyl])adenosine-5'-O-triphosphate (sodium salt)
A fluorescent ATP derivative
Item No. 38443
Formulation: A solution in water
Purity: ≥95%
- Bis-bromo ANT-ATP
2'(3')-O-Anthraniloyladenosine-5'-O-triphosphate (sodium salt)
Fluorescent ATP derivatives
Item No. 38546
Formulation: A solution in water
Purity: ≥95% (mixture of isomers)
- 2'(3')-ANT-ATP
2'(3')-O-
Fluorescent ITP derivatives
Item No. 38446
Formulation: A solution in water
Purity: ≥95% (mixture of isomers)
- 2'-bromo ANT-ITP
2'(3')-O-
Fluorescent GTP derivatives
Item No. 38812
Formulation: A solution in water
Purity: ≥95% (mixture of isomers)
- 2'(3')-ANT-GTP
2'(3')-O-(N'-
Fluorescent GTP derivatives
Item No. 38469
Formulation: A solution in water
Purity: ≥95% (mixture of isomers)
- 2'(3')-MANT-GTP
2'(3')-O-(5-Chloroanthraniloyl)inosine-5'-O-triphosphate (sodium salt)
Fluorescent ITP derivatives
Item No. 38450
Formulation: A solution in water
Purity: ≥95% (mixture of isomers)
- 2'(3')-chloro ANT-ITP
2',3'-O-(Bis-
A fluorescent ATP derivative
Item No. 38444
Formulation: A solution in water
Purity: ≥95%
- Bis-chloro ANT-ATP
2'(3')-O-(5-
Fluorescent ATP derivatives
Item No. 38445
Formulation: A solution in water
Purity: ≥95% (mixture of isomers)
- 2'(3')-bromo ANT-ATP
2'(3')-O-(5-
Fluorescent ATP derivatives
Item No. 38449
Formulation: A solution in water
Purity: ≥95% (mixture of isomers)
- 2'(3')-chloro ANT-ATP
Formulation: A solid
Purity: ≥95%
- BRL 42852ER
- 9(S)-Erythromycylamine
- LY024410
Contact Info
Cayman Chemical1180 East Ellsworth RoadAnn Arbor, Michigan 48108 USAToll Free: (800) 364-9897(USA and Canada only)Fax: (734) 971-3640
